Where Caribou Biosciences Stands With Analysts
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 4 analysts have published their opinion on Caribou Biosciences (NASDAQ:CRBU) stock, all of them being bullish. The average price target is $23.5, implying an upside from the current price of $6.57. This average represents a 4.74% decrease from the previous average price target of $24.67.
July 26, 2023 | 1:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts are bullish on Caribou Biosciences, with an average price target of $23.5, indicating potential upside from the current price.
The unanimous bullish sentiment from analysts, along with the significant potential upside indicated by the average price target, suggests a positive short-term impact on Caribou Biosciences' stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100